Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mifepristone (RU-486) distribution given to new company headed by former generic exec Van Hulst.

Executive Summary

MIFEPRISTONE (RU-486) DISTRIBUTION TO BE HEADED BY FORMER GENERIC EXEC VAN HULST as CEO of a newly- formed for-profit company, Advances for Choice, created by the Population Council, sponsor of the NDA for the abortifacient mifepristone. The Population Council previously intended to distribute the product through a non-profit organization, Advances for Health Technology, which will be subsumed into the new company.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS029731

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel